Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

169.30 -0.50 (-0.29%)

Streaming Delayed Price Updated: 10:36 AM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	155,910
Open	172.55
Bid (Size)	169.00 (200)
Ask (Size)	169.90 (300)
Prev. Close	169.80
Today's Range	167.32 - 173.75
52wk Range	26.70 - 206.71
Shares Outstanding	44,712,538
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

November 20, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards' ↗

November 20, 2025

Short seller challenges Praxis' Phase 3 ulixacaltamide data, alleging major flaws that could undermine FDA approval and the company's valuation.

Via Benzinga

Performance

YTD	+112.9%	+112.9%
1 Month	-2.7%	-2.7%
3 Month	+260.7%	+260.7%
6 Month	+369.0%	+369.0%
1 Year	+126.7%	+126.7%

More News

Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position ↗

November 20, 2025

Via Stocktwits

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

Via MarketMinute

Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today? ↗

October 16, 2025

Via Stocktwits

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 06, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 05, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback

November 04, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

Meet the Biotech Stock That Just Jumped 251% Higher ↗

October 26, 2025

Via The Motley Fool

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket ↗

October 17, 2025

Via Benzinga

Praxis Precision Stock Extends Rally Premarket As Wall Street Turns Hyper-Bullish After Essential Tremor Trial Win ↗

October 17, 2025

Via Stocktwits

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 16, 2025

Via Benzinga

Dow Dips Over 100 Points; US Crude Oil Inventories Surge ↗

October 16, 2025

Via Benzinga

The 'Groundbreaking' Results That Sent Praxis Precision Medicines Up 200% ↗

October 16, 2025

Via Investor's Business Daily

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗

October 16, 2025

Via Benzinga

Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings ↗

October 16, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 16, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 16, 2025

Via Benzinga

Praxis Precision Medicines Stock Doubles - Here's Why ↗

October 16, 2025

Via Benzinga

Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor

October 16, 2025

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Praxis Precision Medicines, Inc. - Common Stock publicly traded?

Yes, Praxis Precision Medicines, Inc. - Common Stock is publicly traded.

What exchange does Praxis Precision Medicines, Inc. - Common Stock trade on?

Praxis Precision Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Praxis Precision Medicines, Inc. - Common Stock?

The ticker symbol for Praxis Precision Medicines, Inc. - Common Stock is PRAX on the Nasdaq Stock Market

What is the current price of Praxis Precision Medicines, Inc. - Common Stock?

The current price of Praxis Precision Medicines, Inc. - Common Stock is 169.30

When was Praxis Precision Medicines, Inc. - Common Stock last traded?

The last trade of Praxis Precision Medicines, Inc. - Common Stock was at 11/24/25 10:36 AM ET

What is the market capitalization of Praxis Precision Medicines, Inc. - Common Stock?

The market capitalization of Praxis Precision Medicines, Inc. - Common Stock is 7.57B

How many shares of Praxis Precision Medicines, Inc. - Common Stock are outstanding?

Praxis Precision Medicines, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.